BioMed Research International / 2020 / Article / Fig 1

Research Article

TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro

Figure 1

TRIM33 is downregulated in various tumors and is related to the progress of ccRCC. (a and b) TRIM33 expression in pan-cancer; red represents tumor tissue and blue represents normal tissue. (c) Analysis of differences in TRIM33 mRNA levels between ccRCC tissues and normal tissues through the UALCAN website based on TCGA. (d–i) The difference in expression of TRIM33 according to individual cancer stages, patient’s gender, patient’s age, tumor grade, KIRC subtypes, and nodal metastasis status. (j) Relationship between TRIM33 expression and survival of renal cell carcinoma patients. (k) KM plot depicting the association of TRIM33 expression levels and tumor grade with patient survival. (l) KM plot depicting the association of TRIM33 expression levels and gender with patient survival. (m and n) The relationship between the expression of TRIM33 in ccRCC and the survival of patients through the HPA website. ; ; ; .
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)
(j)
(k)
(l)
(m)
(n)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.